We previously demonstrated that circulating plasma CXCL9 levels were differentially elevated in the both groups of patients with oral cavity squamous cell carcinoma and nasopharyngeal carcinoma by the multiplex suspension array system, a high-throughput proteomic platform [10]. Here, CXCL9 is linked to oral cavity squamous cell carcinoma.